Articles
View all articles-
Ranbaxy $500 mn fine: Why single out India and Ranbaxy?
Ranbaxy may be facing a potential ban on its generic drugs in United States but however Ranbaxy is not the only company that has faced such a crisis. #WhyNow #Ranbaxy Laboratories #US FDA #generic drugmakers
-
Ranbaxy's $500 mn settlement: All you need to know
Ranbaxy will pay $500 mn to resolve fraud allegations that the company sold adulterated drugs and lied about it to US regulators. #US #CompanyWatch #Ranbaxy #Pharma #generic drugmakers
-
US trade office reviewing SC ruling against Novartis
The United States is considering its response to the Supreme Court ruling against Novartis, which US drug manufacturers warn is the latest sign of a "deteriorating" environment for intellectual property rights in India. #WhatNext #Novartis #big pharma #Drugmakers #US trade body
Wire
-
WTAE PittsburghSupreme Court Ruling: Generic Drugs
The Supreme Court ruled Monday that deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can be sometimes be illegal and therefore challenged by federa #California #Food and Drug Administration #Stephen Breyer
-
The Seattle TimesCourt: 'pay to delay' generic drugs can be illegal
The Supreme Court ruled Monday that deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can be sometimes be illegal and therefore challenged by federa #Food and Drug Administration #Stephen Breyer #John Roberts
-
Mail.comCourt: 'pay to delay' generic drugs can be illegal
WASHINGTON (AP) — The Supreme Court ruled Monday that deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can be sometimes be illegal and therefore ch #Food and Drug Administration #Stephen Breyer #John Roberts